UK Industry Prepares For Post-COVID-19 ‘Normal’ As Non-Urgent And Planned Elective Care Get Green Light
Non-urgent care, ceased by the UK government after the initial surge of COVID-19 cases, is to be restored gradually now that the virus has peaked and new cases are falling. The UK ABHI’s Andrew Davies explains what this means for the medtech industry.
You may also be interested in...
Elective surgery is only “elective” in terms of timing, and is not optional. So says British Orthopaedic Association VP-elect John Skinner in the context of how post-COVID-19 planned care will move forward in the UK.
The evolution of how and where patients receive their care has received an unexpected boost from the COVID-19 crisis. Coronavirus volume testing challenges persist, but the global medtech industry is now looking beyond the crisis toward a return to “normal” business.
Environmental demands, the evolution of care models, new delivery technologies and AI tools are influencing how medtechs must approach innovation.